Baillie Gifford & Co Portfolio holdings
Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.
Top Buys
| 1 |
Microsoft
MSFT
|
$611M |
| 2 |
Shopify
SHOP
|
$441M |
| 3 |
Alibaba
BABA
|
$313M |
| 4 |
NVIDIA
NVDA
|
$189M |
| 5 |
NovoCure
NVCR
|
$171M |
Top Sells
| 1 |
C.H. Robinson
CHRW
|
$389M |
| 2 |
Under Armour
UAA
|
$311M |
| 3 |
Amazon
AMZN
|
$228M |
| 4 |
Meta Platforms (Facebook)
META
|
$199M |
| 5 |
Stellantis
STLA
|
$197M |
Sector Composition
| 1 | Consumer Discretionary | 33.91% |
| 2 | Communication Services | 17.09% |
| 3 | Healthcare | 16.31% |
| 4 | Financials | 10.01% |
| 5 | Technology | 9.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Apple
AAPL
$3.41T
| $26.5M | 0.03% |
139,347
+9,336
| +7% | +$1.77M |
|
152
American Express
AXP
$230B
| $25.9M | 0.03% |
236,838
-2,351
| -1% | -$257K |
|
153
Ameren
AEE
$27B
| $25.7M | 0.03% |
349,085
+11,049
| +3% | +$813K |
|
154
Galicia Financial Group
GGAL
$6.34B
| $25.3M | 0.03% |
991,541
-2,292
| -0.2% | -$58.5K |
|
|
AGR
155
DELISTED
Avangrid, Inc.
AGR
| $24.3M | 0.03% |
483,214
+27,625
| +6% | +$1.39M |
|
156
Banco Macro
BMA
$3.7B
| $24.2M | 0.03% |
528,133
+29,234
| +6% | +$1.34M |
|
157
HEICO
HEI
$44B
| $23.2M | 0.03% |
244,021
-3,989
| -2% | -$378K |
|
|
ZUO
158
DELISTED
Zuora, Inc.
ZUO
| $21.6M | 0.02% |
+1,076,132
| New | +$21.6M |
|
159
Axogen
AXGN
$743M
| $20.7M | 0.02% |
980,700
+343,900
| +54% | +$7.24M |
|
|
JT
160
DELISTED
Jianpu Technology Inc. American Depositary Shares, each representing twenty Class A Ordinary Shares
JT
| $19.4M | 0.02% |
3,871,919
+152,199
| +4% | +$763K |
|
161
Stratasys
SSYS
$882M
| $19.2M | 0.02% |
805,117
+45,226
| +6% | +$1.08M |
|
162
Veeco
VECO
$1.43B
| $17.7M | 0.02% |
1,634,793
+116,207
| +8% | +$1.26M |
|
163
Cullen/Frost Bankers
CFR
$8.3B
| $17.2M | 0.02% |
177,208
+18,307
| +12% | +$1.78M |
|
|
FARO
164
DELISTED
Faro Technologies
FARO
| $17.1M | 0.02% |
389,286
+34,301
| +10% | +$1.51M |
|
165
Ambarella
AMBA
$3.4B
| $17M | 0.02% |
394,410
+17,047
| +5% | +$736K |
|
|
ORTX
166
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $16.5M | 0.02% |
925,000
| – | – |
|
|
ADAP
167
Adaptimmune Therapeutics
ADAP
$15.3M
| $16.5M | 0.02% |
3,839,190
+139,669
| +4% | +$601K |
|
168
Lindblad Expeditions
LIND
$799M
| $16.4M | 0.02% |
1,072,701
| – | – |
|
169
Digimarc
DMRC
$172M
| $16.2M | 0.02% |
517,714
+39,894
| +8% | +$1.25M |
|
170
Dolby
DLB
$6.87B
| $15.5M | 0.02% |
245,708
+11,831
| +5% | +$745K |
|
|
VAR
171
DELISTED
Varian Medical Systems, Inc.
VAR
| $15.4M | 0.02% |
108,904
| – | – |
|
|
KDNY
172
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $15.2M | 0.02% |
3,831,426
+170,253
| +5% | +$678K |
|
173
M&T Bank
MTB
$31.5B
| $15.2M | 0.02% |
96,766
| – | – |
|
174
Johnson & Johnson
JNJ
$429B
| $14.4M | 0.02% |
103,146
+8,280
| +9% | +$1.16M |
|
|
NCNA
175
NuCana
NCNA
$5.69M
| $14.1M | 0.02% |
827,308
| – | – |
|